Magallanes, Zayd Caleb .

HRN: 26-93-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2025
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
04/09/2025
04/15/2025
IVTT
30mg Iv As LD Then 15mg MD
Q48h
Neonatal Pneumonia; T/c MAS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: